Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sturk

Showing results (31-40 of 156) with videos related to

Pageof 16
Sort By:
Progress in Clinical and Biological Research|January 1, 1985
Validity of the endotoxin assay in post surgical patientsH R Büller, J W ten Cate, A Sturk, et al.
Biochimica Et Biophysica Acta|December 29, 1992
Sequence characterization of a sheep cDNA for antithrombin IIIR W Niessen, A Sturk, P L Hordijk, et al.
The Annals of Thoracic Surgery|October 1, 1994
Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypassN Tabuchi, R C Huet, A Sturk, et al.
Thrombosis and Haemostasis|May 9, 2001
Prothrombin time ratio is reduced by magnesium contamination in evacuated blood collection tubesA M van den Besselaar, W van Dam, A Sturk, et al.
Transfusion|March 1, 1982
The effect of storage on platelet morphologyA Sturk, L M Burt, T Hakvoort, et al.
Lipids|December 1, 1991
Studies on the selectivity of enzymes involved in platelet-activating factor formation in stimulated cellsH van den Bosch, A Sturk, J W ten Cate, et al.
Biochimica Et Biophysica Acta|June 13, 1988
Platelet vinculin: a substrate of activated factor XIIIG M Asijee, L Muszbek, J Kappelmayer, et al.
Thrombosis and Haemostasis|June 28, 1983
Detection of carriers in Glanzmann's thrombastheniaG T Zonneveld, E F van Leeuwen, A Sturk, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 23, 1999
[Preeclampsia not (yet) predictable from the blood platelet count]R Lazarov, A Konijnenberg, J A van der Post, et al.
Thrombosis Research|December 14, 2002
Monitoring of unfractionated heparin with the activated partial thromboplastin time: determination of therapeutic rangesA M H P van den Besselaar, A Sturk, G L A Reijnierse
Pageof 16

Showing results (31-40 of 156) with videos related to

Sort By:
Pageof 16
Progress in Clinical and Biological Research|January 1, 1985
Validity of the endotoxin assay in post surgical patientsH R Büller, J W ten Cate, A Sturk, et al.
Biochimica Et Biophysica Acta|December 29, 1992
Sequence characterization of a sheep cDNA for antithrombin IIIR W Niessen, A Sturk, P L Hordijk, et al.
The Annals of Thoracic Surgery|October 1, 1994
Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypassN Tabuchi, R C Huet, A Sturk, et al.
Thrombosis and Haemostasis|May 9, 2001
Prothrombin time ratio is reduced by magnesium contamination in evacuated blood collection tubesA M van den Besselaar, W van Dam, A Sturk, et al.
Transfusion|March 1, 1982
The effect of storage on platelet morphologyA Sturk, L M Burt, T Hakvoort, et al.
Lipids|December 1, 1991
Studies on the selectivity of enzymes involved in platelet-activating factor formation in stimulated cellsH van den Bosch, A Sturk, J W ten Cate, et al.
Biochimica Et Biophysica Acta|June 13, 1988
Platelet vinculin: a substrate of activated factor XIIIG M Asijee, L Muszbek, J Kappelmayer, et al.
Thrombosis and Haemostasis|June 28, 1983
Detection of carriers in Glanzmann's thrombastheniaG T Zonneveld, E F van Leeuwen, A Sturk, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 23, 1999
[Preeclampsia not (yet) predictable from the blood platelet count]R Lazarov, A Konijnenberg, J A van der Post, et al.
Thrombosis Research|December 14, 2002
Monitoring of unfractionated heparin with the activated partial thromboplastin time: determination of therapeutic rangesA M H P van den Besselaar, A Sturk, G L A Reijnierse
Pageof 16